NPI registry status
Active
2026 NPPES data Podiatrist NPI 1013000405 DPM
Verify on CMS → Mark Gasparini, DPM
Podiatrist in Massapequa, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 10,490 in Podiatrist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
206
Medicare Part D claims · 113 beneficiaries · Podiatrist avg: 304
Generic prescribing
92%
generic claims · 8% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
83.2/100
▼ 0 pts below national avg 83.5 · Above neutral
Industry payments
$2.1K
26 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Mark Gasparini, DPM reported a CMS MIPS final score of 83.2/100 - below the 83.5 national average - and filed 206 Medicare Part D claims in 2023.
- 83.2/100
- MIPS score · 0 vs avg
- 206
- Part D claims, 2023
- 92%
- generic prescribing
- $2.1K
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Mark Gasparini, DPM
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1013000405), first enumerated 09/30/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 206 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 83.2/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$2.1K in reported industry payments (26 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
New York statewide board action statistics are published annually — these figures describe aggregate state activity, not Mark Gasparini, DPM's individual license status. Verify directly with the state medical board.
Source: NYSBPMC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1013000405 · Podiatrist
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-INLINE · RX-LIGHT · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1013000405
- ENUM-LEGACY 2006
- TAX-MID 10K Podiatrist
- MIPS-INLINE 83.2/100
- RX-LIGHT 206
- BOOK-LIGHT 1,247 in New York
- PHOTO-FINISH Jason Allen · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Gasparini · this…
Gasparini · this provider
83.2 MIPS pts
- Jill Scholz · hi…
Jill Scholz
83.2 MIPS pts
- Jason Allen · near
Jason Allen
83.2 MIPS pts
- Joseph Addiego ·…
Joseph Addiego
83.2 MIPS pts
- Steve Tung · near
Steve Tung
83.2 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Mark Gasparini, DPM's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
83 ≥ 39th percentile 39% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Mark Gasparini, DPM sits
This provider among podiatrist peers
Across the 2,362 podiatrist providers who report both Medicare Part D prescribing and a MIPS quality score, Mark Gasparini, DPM writes more Part D claims than 50% of them and scores higher on MIPS quality than 59% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one podiatrist peer from a representative sample of 60; the gold marker is Mark Gasparini, DPM. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Mark Gasparini, DPM?
Near national averagePrimary specialty
Podiatrist
Medicare Part D claims
206 32% vs specialty avg
MIPS final score
83.2/100 0.3 pts vs avg
Specialty distribution in New York
How Podiatrist compares to other specialties among New York providers
Medicare quality performance, MIPS
Mark Gasparini, DPM's 2023 MIPS final score plotted against the Podiatrist national average
- MIPS Final Score
- 83.2/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1013000405 |
|---|---|
| Specialty | Podiatrist |
| Credentials | DPM |
| Gender | Male |
| NPI Issued | 09/30/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
83.223
Final Score
Measured-score avg: 83.5
47.1595
Quality
Reporting: Individual
Hospital and facility affiliations
Facilities where Mark Gasparini, DPM bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Mark Gasparini, D.p.m. P.C.
Massapequa, NY
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mark Gasparini, DPM. Source: openpaymentsdata.cms.gov.
Total received
$2.1K
Largest payer
TREACE MEDICAL CONCEPTS, INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Mark Gasparini, DPM. To verify Mark Gasparini, DPM's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
Mark Gasparini, DPM - brand share 8.0%
Podiatrist average
8% brand-name claims vs 92% generic, on 206 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
206
Total Claims
$12K
Total Drug Cost
113
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 222
- Total Day Supply
- 4,557
- Brand vs Generic
- 8% brand / 92% generic
- Brand Drug Cost
- $7K
- Generic Drug Cost
- $5K
- Antibiotic Claims
- 41
Patient Demographics
- Average Patient Age
- 79.2 years
- Avg HCC Risk Score
- 2.06
- Gender Split
- 53% female / 47% male
- Age Distribution
- <65: 13, 65-74: 23, 75-84: 30, 85+: 47
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Mark Gasparini, DPM prescribes most
Top Medicare Part D drugs by claim count, 2023
- Clotrimazole-Betam…
Clotrimazole-Betamethasone
34 claims
- Mupirocin
Mupirocin
26 claims
- Amoxicillin-Clavul…
Amoxicillin-Clavulanate Potass
22 claims
- Clotrimazole 12
Clotrimazole
12 claims
- Doxycycline Hyclate 12
Doxycycline Hyclate
12 claims
- Venlafaxine Hcl Er 11
Venlafaxine Hcl Er
11 claims
| Drug | Claims |
|---|---|
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 34 |
| Mupirocin | 26 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 22 |
| Clotrimazole | 12 |
| Doxycycline Hyclate | 12 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Podiatrist Overview
How Mark Gasparini, DPM fits within the Podiatrist landscape nationally.
10,490
Podiatrist Providers in US
54
States with Podiatrist
304
Avg Claims per Provider
Mark Gasparini, DPM's 206 claims are below the specialty average of 304.
Nationwide Podiatrist peers with similar MIPS or enrollment year
Two federal-record peer sets for Gasparini, both outside New York so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (83.2 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Podiatrist Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Gasparini.
One of 1,247 Podiatrist providers enrolled in New York, 5 are shown here.
Dr. Audrey Abatemarco
DPM
New York, NY
Dr. Herbert Abbott
D.P.M.
New York, NY
Dr. Sarah Abdou
DPM
Larchmont, NY
Dr. Bruce Abel
D.P.M.
Yonkers, NY
Dr. Rosalind Abel
D.P.M.
Yonkers, NY
Compare Podiatrist nationally: see state-by-state distribution →
Frequently Asked Questions
What is Mark Gasparini, DPM's specialty? ▼
Mark Gasparini, DPM specializes in Podiatrist and practices in Massapequa, New York. Credentials: DPM.
How much does Mark Gasparini, DPM prescribe under Medicare Part D? ▼
In 2023, Mark Gasparini, DPM wrote 206 Medicare Part D claims totaling $12K in drug costs for 113 beneficiaries.
What is Mark Gasparini, DPM's Medicare quality score? ▼
Mark Gasparini, DPM has a CMS MIPS Final Score of 83.2/100 (Quality: 47.2). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Mark Gasparini, DPM located? ▼
Mark Gasparini, DPM is located at 119 NEW YORK AVE, Massapequa, NY, 11758. Phone: (516) 804-9038.
What is Mark Gasparini, DPM's NPI number? ▼
Mark Gasparini, DPM's National Provider Identifier (NPI) is 1013000405, issued on 09/30/2006.
Does Mark Gasparini, DPM prescribe more brand-name or generic drugs? ▼
Mark Gasparini, DPM's prescribing is 8% brand-name and 92% generic drugs by claim count, with $7K in brand drug costs.
How many Podiatrist providers are there in the US? ▼
There are 10,490 Podiatrist providers across 54 states in the US. The average Podiatrist provider writes 304 Medicare Part D claims per year.
What drugs does Mark Gasparini, DPM prescribe most often? ▼
Based on 2023 Medicare Part D data, Mark Gasparini, DPM's most frequently prescribed drugs include Clotrimazole-Betamethasone, Mupirocin, Amoxicillin-Clavulanate Potass. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mark Gasparini, DPM accept Medicare? ▼
Mark Gasparini, DPM appears in CMS Medicare data with 206 Part D claims and 113 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mark Gasparini, DPM's credentials? ▼
Mark Gasparini, DPM's NPI is 1013000405 with credentials DPM. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.